Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Mesoblast reports positive outcomes from phase II trial on back pain

Jan. 30, 2014

Seikagaku files for Japanese approval of SI-6603 for treatment of lumbar disc herniation

Jan. 30, 2014

Ares Trading, a subsidiary of Merck Serono, patents new IRAK-4 inhibitors

Jan. 30, 2014

Genentech and Roche disclose new ROR-gamma modulators

Jan. 29, 2014

Canadian group discloses novel BTK inhibitors

Jan. 27, 2014

Gilead Sciences divulges novel JAK inhibitors

Jan. 22, 2014

Hanmi Pharmaceutical designs new CSF-1R inhibitors

Jan. 22, 2014

Novel EP4 receptor antagonists presented by Eli Lilly

Jan. 22, 2014

Pluristem's phase I/II trial of PLX-PAD cells in muscle injury meets primary endpoints

Jan. 21, 2014

Merck & Co. researchers report discovery of SYK inhibitors

Jan. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...